Overview

Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This study is an efficacy evaluation of DotaremĀ®-enhanced magnetic resonance angiography (MRA) compared to GadovistĀ®-enhanced MRA in the diagnosis of clinically significant abdominal or lower limb arterial diseases.
Phase:
Phase 4
Details
Lead Sponsor:
Guerbet
Treatments:
Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate